197 related articles for article (PubMed ID: 28921875)
1. Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
Tanner RM; Shimbo D; Irvin MR; Spruill TM; Bromfield SG; Seals SR; Young BA; Muntner P
J Clin Hypertens (Greenwich); 2017 Nov; 19(11):1117-1124. PubMed ID: 28921875
[TBL] [Abstract][Full Text] [Related]
2. Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.
Mwasongwe SE; Tanner RM; Poudel B; Pugliese DN; Young BA; Abdalla M; Musani SK; Gutiérrez OM; Correa A; Shimbo D; Muntner P
Clin J Am Soc Nephrol; 2020 Apr; 15(4):501-510. PubMed ID: 32217635
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; Warnock D; Muntner P
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1583-90. PubMed ID: 23868902
[TBL] [Abstract][Full Text] [Related]
5. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
[TBL] [Abstract][Full Text] [Related]
6. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
Akinyelure OP; Jaeger BC; Safford MM; Oparil S; Carson AP; Sims A; Hannon L; Howard G; Muntner P; Hardy ST
J Am Heart Assoc; 2024 May; 13(10):e031695. PubMed ID: 38752519
[TBL] [Abstract][Full Text] [Related]
7. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
Am J Hypertens; 2024 May; 37(6):438-446. PubMed ID: 38436491
[TBL] [Abstract][Full Text] [Related]
8. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
[TBL] [Abstract][Full Text] [Related]
12. Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
Langford AT; Akinyelure OP; Moore TL; Howard G; Min YI; Hillegass WB; Bress AP; Tajeu GS; Butler M; Jaeger BC; Yano Y; Shimbo D; Ogedegbe G; Calhoun D; Booth JN; Muntner P
Hypertension; 2020 Nov; 76(5):1600-1607. PubMed ID: 32924633
[TBL] [Abstract][Full Text] [Related]
13. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
[TBL] [Abstract][Full Text] [Related]
14. Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease.
Tsuchimoto A; Tanaka S; Kitamura H; Hiyamuta H; Tsuruya K; Kitazono T; Nakano T;
Clin Exp Nephrol; 2022 Nov; 26(11):1100-1110. PubMed ID: 35927602
[TBL] [Abstract][Full Text] [Related]
15. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
[TBL] [Abstract][Full Text] [Related]
16. Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes.
Viazzi F; Greco E; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
Kidney Blood Press Res; 2018; 43(2):422-438. PubMed ID: 29698970
[TBL] [Abstract][Full Text] [Related]
17. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
[TBL] [Abstract][Full Text] [Related]
18. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study.
Tangkiatkumjai M; Walker DM; Praditpornsilpa K; Boardman H
Clin Exp Nephrol; 2017 Jun; 21(3):504-512. PubMed ID: 27438073
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
[TBL] [Abstract][Full Text] [Related]
20. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
